Issue 6/2017
Content (9 Articles)
Acknowledgement to Referees
ACKNOWLEDGEMENT TO REFEREES
Current Opinion
Next-Generation Chimeric Antigen Receptor T-Cell Therapy: Going off the Shelf
Marco Ruella, Saad S. Kenderian
Commentary
The Application of CGRP(r) Monoclonal Antibodies in Migraine Spectrum: Needs and Priorities
Paolo Martelletti
Review Article
CGRP Monoclonal Antibodies for Migraine: Rationale and Progress
Hsiangkuo Yuan, Clinton G. Lauritsen, Eric A. Kaiser, Stephen D. Silberstein
Review Article
Delivery of Biologics Across the Blood–Brain Barrier with Molecular Trojan Horse Technology
William M. Pardridge
Open Access
Review Article
Recent Developments in ADC Technology: Preclinical Studies Signal Future Clinical Trends
Penelope M. Drake, David Rabuka
Original Research Article
Impact of Infliximab and Etanercept Biosimilars on Biological Disease-Modifying Antirheumatic Drugs Utilisation and NHS Budget in the UK
Mohammed I. Aladul, Raymond W. Fitzpatrick, Stephen R. Chapman
Open Access
Original Research Article
Response to Tetanus and Pneumococcal Vaccination Following Administration of Ixekizumab in Healthy Participants
Elisa V. Gomez, Jessie L. Bishop, Kimberley Jackson, Talia M. Muram, Diane Phillips